ReutersReuters

Saudi's Avalon Pharma Posts Qtrly Profit

MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY 44016:

  • QTRLY NET PROFIT 9.37 MILLION RIYALS VERSUS LOSS 0.5 MILLION RIYALS YEAR AGO

  • QTRLY SALES 75.82 MILLION RIYALS VERSUS 55.23 MILLION RIYALS YEAR AGO

  • QUARTER SAW STRONG SALES PERFORMANCE IN ALL DISTRIBUTION CHANNELS

Login or create a forever free account to read this news